Integrin αvβ8–expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells

TGF-β is a promising immunotherapeutic target. It is expressed ubiquitously in a latent form that must be activated to function. Determination of where and how latent TGF-β (L-TGF-β) is activated in the tumor microenvironment could facilitate cell- and mechanism-specific approaches to immunotherapeu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JCI Insight
Päätekijät: Takasaka, Naoki, Seed, Robert I., Cormier, Anthony, Bondesson, Andrew J., Lou, Jianlong, Elattma, Ahmed, Ito, Saburo, Yanagisawa, Haruhiko, Hashimoto, Mitsuo, Ma, Royce, Levine, Michelle D., Publicover, Jean, Potts, Rashaun, Jespersen, Jillian M., Campbell, Melody G., Conrad, Fraser, Marks, James D., Cheng, Yifan, Baron, Jody L., Nishimura, Stephen L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Clinical Investigation 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237456/
https://ncbi.nlm.nih.gov/pubmed/30333313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122591
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia